Baxion
Screening
Tags
Alerts
Theme
Onkure Therapeutics, Inc.
OKUR
·
NASDAQ
·
$4.12
Share Price as of 11/2
·
$56M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/04/26
10-Q
Q1 ended 03/31/26
05/05/26
10-K
FY 2025
03/12/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/12/25
Disclosures
Filter
8-K
Current report
08/13/26
8-K
Current report
08/04/26
8-K
Current report
06/04/26
8-K
Current report
05/05/26
8-K
Current report
03/30/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
08/04/26
S-8
Registration of securities for employees
06/05/26
S-3
Shelf registration
04/24/26
S-8
Registration of securities for employees
03/12/26
424B3
Prospectus
11/21/25
Proxies
Filter
DEF 14A
Definitive proxy
04/21/26
DEFA14A
Additional proxy materials
04/21/26
DEF 14A
Definitive proxy
04/16/25
DEFA14A
Additional proxy materials
04/16/25
DEF 14A
Definitive proxy
04/26/23
Ownership
Filter
SC 13G
Beneficial ownership
10/07/26
Form 4
Insider transaction
09/23/26
Form 4
Insider transaction
09/23/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Other
Filter
EFFECT
Request for effectiveness
05/04/26
CORRESP
Correspondence with the SEC
04/30/26
UPLOAD
Letter from the SEC
04/30/26
ARS
Annual report to shareholders
04/21/26
EFFECT
Request for effectiveness
11/18/25
Latest Filings
Filter
8-K
Current report
08/13/26
10-Q
Q2 ended 06/30/26
08/04/26
8-K
Current report
08/04/26
424B5
Prospectus supplement
08/04/26
S-8
Registration of securities for employees
06/05/26
Ownership
Filter
SC 13G
Beneficial ownership
10/07/26
Form 4
Insider transaction
09/23/26
Form 4
Insider transaction
09/23/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/14/26